ABSA International
ABSA International

Resources with keywords: vaccines



Spikevax and Moderna COVID-19 Vaccine (Website, Regulatory)
FDA
31 January 2022

The FDA has given full approval to the Moderna COVID-19 Vaccine which will now be marketed as Spikevax, for the prevention of COVID-19 in individuals 18 years of age and older.

keywords: covid-19, vaccines
Efficacy of an inactivated Zika vaccine against virus infection during pregnancy in mice and marmosets
Nature
27 January 2022

In-Jeong K, et.al.
A Zika virus vaccine candidate is effective at preventing the Zika virus passing from mother to fetus in preclinical animal studies.

Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth — Eight Integrated Health Care Organizations, United States, December 15, 2020–July 22, 2021 (NEW 2/3, Website, Publication)
CDC/MMWR
7 January 2022

Lipkind HS, Vazquez-Benitez G, DeSilva M, et al.

In a retrospective cohort of >40,000 pregnant women, COVID-19 vaccination during pregnancy was not associated with preterm birth or small-for-gestational-age at birth overall, stratified by trimester of vaccination, or number of vaccine doses received during pregnancy, compared with unvaccinated pregnant women.

HKU microbiologists find that two doses of BNT162b2 (BioNTech ) or Coronavac (Sinovac) vaccines are inadequate against Omicron virus variants
University of Hong Kong
14 December 2021
Key Things to Know About COVID-19 Vaccines
CDC

Good summary of vaccine information (elegibility, ages, boosters, side effects, safety, etc.).

A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient (NEW 2/3, Website, Publication)
International Journal of Infectious Diseases
1 December 2021

Maruki T, et al.

We encountered a patient who developed VZV meningitis shortly after receiving the first dose of the BNT162b2 mRNA COVID-19 vaccine.

New Clues Emerge About Whether Vaccines Can Help Fight Long Covid (NEW 11/2, Document, News)
Wall Street Journal (WSJ)
12 October 2021

The latest research suggests that vaccinations help reduce the likelihood of developing
longer-term symptoms after a Covid-19 infection and may help some people with
symptoms feel better.

The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency (NEW 11/2, Website, Publication)
Nature (Cellular & Molecular Immunology)
25 October 2021

Arora P, Rocha C, Kempf A, et al.

COVID-19 Vaccine Booster Shots (NEW 11/2, Website, Regulatory)
CDC
5 November 2021
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021 (NEW 11/2, Website, Publication)
CDC/MMWR
5 November 2021

Olson SM, Newhams MM, Halasa NB, et al.

Go to Top